| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |